ACVRL1 and pulmonary arterial hypertension: Also, in 7 out of 9 individuals with ACVRL1 mutations in the French registry of PAH patients, the diagnosis of PAH preceded that of HHT (Girerd et al., 2010), suggesting that ACVRL1 mutations may predispose to HHT or PAH.